Holista CollTech

Sydney, Australia Founded: 2000 • Age: 26 yrs
Medical-grade collagen, supplements, and food ingredients are produced.
Annual revenue $3.5M Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 11 Brand Intelligence

About Holista CollTech

Holista CollTech is a company based in Sydney (Australia) founded in 2000. Holista CollTech operates in a competitive market with competitors including Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others.

  • Headquarter Sydney, Australia
  • Stage Public
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Holista Colltech Limited
Operational Areas
Healthcare → Nutrition, Wellness & Lifestyle Health Unlock Sub-Sector Unlock Segment
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $3.47 M (USD)
    -5.86
    as on Dec 31, 2024
  • Net Profit
    -$52.16 K (USD)
    98.25
    as on Dec 31, 2024
  • EBITDA
    -$537.34 K (USD)
    60.64
    as on Dec 31, 2024
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Holista CollTech

Holista CollTech is a publicly listed company on the ASX with ticker symbol HCT in Australia, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: ASX · Ticker: HCT · Sector: Health technology · Australia

Funding Insights of Holista CollTech

Premium access

Detailed funding history for Holista CollTech

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Holista CollTech

Investments
Premium access

Investment portfolio details for Holista CollTech

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Holista CollTech

Premium access

Detailed financials for Holista CollTech

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Holista Colltech Comparisons

Holista CollTech Primary company
Description
Medical-grade collagen, supplements, and food ingredients ar...
Location
Sydney, Australia
Founded Year
2000
Annual Revenue
$3.47 M (USD)
Net Profit
-$52.16 K (USD)
EBITDA
-$537.34 K (USD)
Employees
Not available
Premium access

Peer comparison for Holista CollTech

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Holista CollTech

Holista CollTech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Antibody-siRNA complexes are developed for cancer treatment.
Locked Locked Locked
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
Locked Locked Locked
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
Locked Locked Locked
Developing novel drugs based on a proteome-wide ligand and target discovery platform
Locked Locked Locked
Dental implants and regenerative dentistry products are developed.
Locked Locked Locked
RNA-editing technologies are provided for precision medicine applications.
Premium access

Detailed competitors of Holista CollTech

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Holista Colltech

Premium access

Complete news archive for Holista CollTech

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Holista CollTech

Holista CollTech was founded in 2000.

Holista CollTech is headquartered in Sydney, Australia. It is registered at Sydney, New South Wales, Australia.

Annual revenue of Holista CollTech is $3.47M as on Dec 31, 2024.

Holista CollTech was founded in 2000 and is based in Sydney, Australia. Operations focus on the health and food sectors, where medical-grade collagen is extracted from sheep using a patented method. Methods for nano and liposome encapsulation of ovine collagen are being developed. Natural health supplements and food ingredients are also manufactured by the company.

Holista CollTech's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.

Yes, Holista CollTech is publicly traded on ASX under the ticker symbol HCT.

The ticker symbol of Holista CollTech is HCT on ASX.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available